|
The Division of Vascular Surgery is a leader in research and development of vascular surgical techniques, and has been responsible for numerous advancements in the field. The Mount Sinai Center for Endovascular Surgery, founded in January 1997, and led by Dr. Michael L. Marin, is one of the leading endovascular stent-graft centers in the country, and has implanted nearly 1,000 stent-grafts in patients with aortic aneurysms in the course of conducting research.
Since 1997, the Division has participated in over 14 research studies, including:
- Six studies that assessed the use of endovascular stent-graft repair in patients with abdominal aortic aneurysms, with some patients followed-up on for as long as 8 years, with excellent outcomes.
- Seven studies that assessed the use of endovascular stent-graft repair in patients with thoracic aortic aneurysms in high risk and low risk populations. Two of these studies contributed to the FDA's approval of the first thoracic stent-graft on the market.
- A study of the enzymatic effects of CGT-003 on vein bypass grafts in patients undergoing lower extremity bypass graft.
- A study of the use of chronic non-invasive pressure transducers as tool of surveillance following an endovascular stent-graft repair of an abdominal aortic aneurysm. The Division was the first site in the country to conduct such a study, and was also the first site to publish reports on its findings. This method may be first of its kind to analyze the change in pressure in the aneurysm sac following a stent-graft procedure and its correlation with presence of endoleak and the complete exclusion of the aneurysm sac.
|
